Product Description
GLUFALL-G1 contains Glimpride 1Mg + Metformin 500 Mg SR , a combination oral antidiabetic formulation containing glimepiride and sustained-release metformin. Glimepiride belongs to the sulfonylurea group and works by promoting insulin release from the pancreas, while metformin helps reduce glucose production in the liver and supports better insulin sensitivity.The sustained-release formulation gradually releases metformin over an extended period. Doctors use it as part of a comprehensive Type 2 diabetes management plan alongside an appropriate diet, exercise, and medical supervision.





